Cargando…

Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy

BACKGROUND: Since the ToGA trial, trastuzumab-based chemotherapy is the standard treatment for HER2 positive stage IV gastric cancer. However, it is not yet clear whether surgical resection after trastuzumab-based chemotherapy (conversion surgery) can improve survival of HER2 positive stage IV gastr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayano, Koichi, Watanabe, Hiroki, Ryuzaki, Takahiro, Sawada, Naoto, Ohira, Gaku, Kano, Masayuki, Uesato, Masaya, Matsubara, Hisahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516002/ https://www.ncbi.nlm.nih.gov/pubmed/32970254 http://dx.doi.org/10.1186/s40792-020-00984-w

Ejemplares similares

A case report of duodenal arteriovenous malformation: usefulness of intraoperative indocyanine green angiography for precise identification of the lesion
por: Kurata, Yoshihiro, et al.
Publicado: (2022)

Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
por: Kano, Masayuki, et al.
Publicado: (2019)

Short‐term clinical outcomes of laparoscopic gastrectomy for remnant gastric cancer: A single‐institution experience and systematic review of the literature
por: Otsuka, Ryota, et al.
Publicado: (2018)

Magnetic compression anastomosis is effective in treating stenosis after esophageal cancer surgery: a case report
por: Isozaki, Tetsuro, et al.
Publicado: (2020)

Predictor of respiratory disturbances during gastric endoscopic submucosal dissection under deep sedation
por: Aikawa, Mizuho, et al.
Publicado: (2020)

Incidence and risk factor of outlet obstruction after construction of ileostomy
por: Ohira, Gaku, et al.
Publicado: (2018)

Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET
por: Narushima, Kazuo, et al.
Publicado: (2023)

Polysomnographic assessment of respiratory disturbance during deep propofol sedation for endoscopic submucosal dissection of gastric tumors
por: Urahama, Ryuma, et al.
Publicado: (2018)

Imaging biomarkers for the treatment of esophageal cancer
por: Hayano, Koichi, et al.
Publicado: (2019)

Preoperative chemoradiotherapy using S-1 combined with celecoxib for advanced lower rectal cancer: Phase I/II study
por: Ohira, Gaku, et al.
Publicado: (2019)

Probable IgG4-related sclerosing disease presenting as a gastric submucosal tumor with an intense tracer uptake on PET/CT: a case report
por: Otsuka, Ryota, et al.
Publicado: (2016)

Laparoscopic double-tract reconstruction after total gastrectomy for postoperative duodenal surveillance: Case series
por: Otsuka, Ryota, et al.
Publicado: (2017)

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
por: Arasawa, Takahiro, et al.
Publicado: (2023)

Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma
por: Sekino, Nobufumi, et al.
Publicado: (2019)

Preserving the Mucosa to the Maximum Possible Extent for Endoscopic Submucosal Dissection of Subcircumferential Superficial Esophageal Carcinoma
por: Uesato, Masaya, et al.
Publicado: (2018)

Continuous suturing with a stay suture after endoscopic full-thickness resection in an experimental study
por: Uesato, Masaya, et al.
Publicado: (2022)

Small bowel adenocarcinomas with favorable prognoses by radical resection and adjuvant chemotherapy: a case series of five cases
por: Nishioka, Yuri, et al.
Publicado: (2023)

Gastric endoscopic submucosal dissection via gastrostoma before the second operation for esophageal perforation: A case report
por: Sasaki, Takuma, et al.
Publicado: (2018)

Occurrence of Cortical Arousal at Recovery from Respiratory Disturbances during Deep Propofol Sedation
por: Urahama, Ryuma, et al.
Publicado: (2019)

Role of sirtuins in esophageal cancer: Current status and future prospects
por: Otsuka, Ryota, et al.
Publicado: (2022)

RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity
por: Morinaka, Takashi, et al.
Publicado: (2023)

Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines
por: Matsumoto, Yasunori, et al.
Publicado: (2020)

Preoperative hepatic CT perfusion as an early predictor for the recurrence of esophageal squamous cell carcinoma: Initial clinical results
por: FUJISHIRO, TAKESHI, et al.
Publicado: (2014)

Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer
por: Sato, Nami, et al.
Publicado: (2022)

A case of small-cell esophageal cancer with chronic renal failure undergoing hemodialysis safely treated with cisplatin and etoposide
por: Murakami, Kentaro, et al.
Publicado: (2011)

Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy
por: Zhang, Yanqiang, et al.
Publicado: (2022)

Tumor-suppressive role of Smad ubiquitination regulatory factor 2 in patients with colorectal cancer
por: Sato, Nami, et al.
Publicado: (2022)

Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients
por: Uesato, Masaya, et al.
Publicado: (2017)

Soluble PD‑L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse‑free survival after radical surgery
por: Matsumoto, Yasunori, et al.
Publicado: (2023)

Endoscopic occlusion with silicone spigots for the closure of refractory esophago-bronchiole fistula after esophagectomy
por: Uesato, Masaya, et al.
Publicado: (2017)

Effect of Trastuzumab–HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab
por: Spanov, Baubek, et al.
Publicado: (2022)

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer
por: Watanabe, Satomi, et al.
Publicado: (2019)

Lowering the setting value of the esophageal endoscopic submucosal dissection device enabled tissue damage control in vitro porcine model
por: Yamaguchi, Yukiko, et al.
Publicado: (2022)

HER2 therapy: Molecular mechanisms of trastuzumab resistance
por: Nahta, Rita, et al.
Publicado: (2006)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Quantification of Trastuzumab–HER2 Engagement In Vitro and In Vivo
por: Rudkouskaya, Alena, et al.
Publicado: (2020)

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer
por: Wakatsuki, Takeru, et al.
Publicado: (2018)

Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
por: Yang, Jiangping, et al.
Publicado: (2022)

A case report of pulmonary tumor thrombotic microangiopathy (PTTM) caused by esophageal squamous cell carcinoma
por: Fujishiro, Takeshi, et al.
Publicado: (2013)

Drill needle aspiration biopsy for submucosal tumors in an experimental study
por: Uesato, Masaya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8keibclu6tvu5rt2qpik6cok8